Stoneridge Announces Chief Financial Officer Departure
SRINOVI, Mich., Feb. 2, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced that Chief Financial Officer and Treasurer, Matt Horvath, has resigned, effective March 31, 2026, to pursue an opportunity in a different industry sector. Horvath will continue to serve in his role...
Marine Collagen and Peptides in Skincare and Anti-Aging Products Market Set to Double by 2033, Driven by 'Blue Beauty' and Clean Label Trends - Strategic Revenue Insights (SRI)
SRILONDON, Jan. 26, 2026 /PRNewswire/ -- The global beauty and wellness industry is witnessing a significant paradigm shift as consumer preference pivots toward marine-sourced ingredients. A comprehensive new market research report titled Marine Collagen & Peptides in Skincare & Anti-Aging...
Hyaluronic Acid Skin Care Products Market Set to Reach USD 3.90 Billion by 2033 as Global Demand for Advanced Hydration Surges Strategic Revenue Insights (SRI)
SRILONDON, Jan. 19, 2026 /PRNewswire/ -- Strategic Revenue Insights Inc. - The global Hyaluronic Acid Skin Care Products Market is entering a period of accelerated, data-backed expansion, driven by rising consumer preference for scientifically validated hydration solutions and rapidly...
Advanced Coatings and Functional Chemicals Market to Reach USD 485.40 Billion by 2033 Amid Sustainability and High-Performance Demand Strategic Revenue Insights (SRI)
SRILONDON, Jan. 12, 2026 /PRNewswire/ -- Strategic Revenue Insights Inc. - The Advanced Coatings and Functional Chemicals Market is entering a decisive phase of accelerated, data-driven growth, underpinned by industrial modernization, sustainability mandates, and rising performance...
Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars by 2033 - Strategic Revenue Insights (SRI)
SRILONDON, Dec. 1, 2025 /PRNewswire/ -- Strategic Revenue Insights Inc. - The global landscape of advanced therapeutics is undergoing one of its most transformative phases, led by the rapid rise of next-generation biologics and biosimilars. As healthcare systems confront rising chronic...
Sparton Annual General Meeting Elects Two New Strategic Directors Bringing New Expertise to the Board
SRI(NYSE:SRI) TORONTO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sparton Resources Inc. (TSXV-SRI) ("Sparton" or the "Company”) announced today that its Annual General Meeting, held Wednesday, August 6, 2025, resulted in the election of two new members to the Board of Directors with over 99% of the votes cast approving their election. The new members bring additional expertise to the Board in several areas and will be invaluable going forward.
Stoneridge Reports Second Quarter 2025 Results
SRIMirrorEye® Sets Another Quarterly Sales Record Announces Largest Business Award in Company History for Global MirrorEye Program Announces Largest OEM Business Award in Stoneridge Brazil History Announces Review of Strategic Alternatives for Control Devices Business 2025 Second Quarter...
Schrödinger Reports Second Quarter 2025 Financial Results
SRINEW YORK--(BUSINESS WIRE)--Schrödinger today announced financial results for the quarter ended June 30, 2025.
Barrington Research Maintains Outperform on Stoneridge, Maintains $16 Price Target
SRIStoneridge Affirms FY2025 Sales Guidance of $860.00M-$890.00M vs $871.40M Est
SRIStoneridge Q1 Adj. EPS $(0.19) Misses $(0.17) Estimate, Sales $217.89M Beat $209.60M Estimate
SRIA Preview Of Stoneridge's Earnings
SRIBreaking Down Stoneridge: 4 Analysts Share Their Views
SRIBarrington Research Maintains Outperform on Stoneridge, Maintains $16 Price Target
SRIBarrington Research Maintains Outperform on Stoneridge, Maintains $16 Price Target
SRIBarrington Research Maintains Outperform on Stoneridge, Maintains $16 Price Target
SRIStoneridge FY2026 Revenue expected to be more than 975M
SRIStoneridge Sees FY2025 Sales $860.000M-$890.000M vs $948.78M Est
SRIStoneridge Q4 Adj $(0.18) Misses $(0.04) Estimate, Sales $218.20M Miss $222.04M Estimate
SRIBarrington Research Maintains Outperform on Stoneridge, Maintains $16 Price Target
SRIStoneridge Q1 Sales $221.06M Beat $194.78M Estimate
SRI